ADC Therapeutics Licenses Proprietary Antibodies from Five Prime Therapeutics

News   Nov 07, 2013

 
ADC Therapeutics Licenses Proprietary Antibodies from Five Prime Therapeutics
 
 
 
FURTHER INFORMATION
 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 
 

Comments | 0 ADD COMMENT